1. COVID-19 and melanoma surgery in a dermo-oncology centre in Italy
- Author
-
Francesca Pepe, Alessia Barisani, Annalisa Patrizi, Carlotta Baraldi, Emi Dika, Sabina Vaccari, and Emi Dika, Alessia Barisani, Carlotta Baraldi, Francesca Pepe, Annalisa Patrizi, Sabina Vaccari
- Subjects
medicine.medical_specialty ,Delayed Diagnosis ,Skin Neoplasms ,COVID-19 ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Dermatology ,Delayed diagnosis ,Time-to-Treatment ,surgery ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Pandemic ,Correspondence ,medicine ,Humans ,Melanoma diagnosis ,Melanoma ,Pandemics ,business.industry ,SARS-CoV-2 ,pandemic ,medicine.disease ,Letter To The Editor ,diagnosi ,Italy ,030220 oncology & carcinogenesis ,Cutaneous melanoma ,Skin cancer ,business - Abstract
We have read with great interest the scientific literature regarding the diagnosis and treatment of skin cancer during COVID-19 pandemic.1-5 The cancellation of routine dermatologic visits could lead to the risk of neglecting cutaneous melanoma (CM), with potential consequences in terms of morbidity and mortality,1,2 even though the specific impact of the pandemic on CM has yet to be estimated.
- Published
- 2021